1 | Benralizumab (D09874) | 1件: Benralizumab Benralizumab | 1件: Benralizumab
Benralizumab
(D09874) 💬
| 1件: IL5RA IL5RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 💬
|
2 | Biological: Benralizumab, Biological: Placebo to Mepolizumab (D09874) | 2件: Benralizumab Benralizumab, Mepolizumab | 2件: Mepolizumab
Mepolizumab
,
Benralizumab
(D09874) 💬
| 2件: IL5 IL5, IL5RA 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 44 44 💬
|
3 | Biological: Mepolizumab, Biological: Placebo to Benralizumab (D09874) | 2件: Benralizumab Benralizumab, Mepolizumab | 2件: Mepolizumab
Mepolizumab
,
Benralizumab
(D09874) 💬
| 2件: IL5 IL5, IL5RA 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 44 44 💬
|